Filing Details
- Accession Number:
- 0001225208-13-017644
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-12 16:11:38
- Reporting Period:
- 2013-08-08
- Filing Date:
- 2013-08-12
- Accepted Time:
- 2013-08-12 16:11:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385187 | Covidien Plc | COV | Surgical & Medical Instruments & Apparatus (3841) | 980624794 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1469178 | P Michael Dunford | C/O Covidien 15 Hampshire Street Mansfield MA 02048 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2013-08-08 | 8,200 | $63.82 | 18,060 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $63.7800 to $63.8300. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each separate price.
- Includes unvested restricted stock units and associated unvested dividend equivalent units, the number of which were adjusted in connection with the recent spin-off of Covidien's pharmaceuticals business. Also includes 38 shares acquired in connection with the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
Billionaire Hedge Funds
